Skip to content
10-Q

Quarterly Report

Olema Pharmaceuticals, Inc. OLMA

0001193125-25-273236

← back to feed
Filed
Nov 10, 2025 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q3 2025 · Nov 6, 2025 68.66M sh
Shares Diluted Q3 2025 · Sep 30, 2025 85.73M sh
Shares Diluted Q3 2025 · Sep 30, 2025 85.55M sh
Shares Diluted Q3 2025 · Sep 30, 2024 57.26M sh
Shares Diluted Q3 2025 · Sep 30, 2024 53.19M sh
Capex Q3 2025 · Sep 30, 2025 $0
Capex Q3 2025 · Sep 30, 2024 $159K
Operating Cash Flow Q3 2025 · Sep 30, 2025 −$108.39M
Operating Cash Flow Q3 2025 · Sep 30, 2024 −$78.07M
Cash And Equivalents Q3 2025 · Sep 30, 2025 $35.26M
Cash And Equivalents Q3 2025 · Dec 31, 2024 $139.48M
Stockholders Equity Q3 2025 · Sep 30, 2025 $307.49M
Stockholders Equity Q3 2025 · Jun 30, 2025 $345.24M
Stockholders Equity Q3 2025 · Dec 31, 2024 $408.96M
Stockholders Equity Q3 2025 · Sep 30, 2024 $198.91M
Stockholders Equity Q3 2025 · Jun 30, 2024 $227.16M
Stockholders Equity Q3 2025 · Dec 31, 2023 $253.9M
Current Liabilities Q3 2025 · Sep 30, 2025 $41.66M
Current Liabilities Q3 2025 · Dec 31, 2024 $41.76M
Total Liabilities Q3 2025 · Sep 30, 2025 $44.97M
Total Liabilities Q3 2025 · Dec 31, 2024 $42.02M
Current Assets Q3 2025 · Sep 30, 2025 $334.33M
Current Assets Q3 2025 · Dec 31, 2024 $438.47M
Total Assets Q3 2025 · Sep 30, 2025 $352.45M
Total Assets Q3 2025 · Dec 31, 2024 $450.98M
Eps Diluted Q3 2025 · Sep 30, 2025 −$0.49
Eps Diluted Q3 2025 · Sep 30, 2025 −$1.36
Eps Diluted Q3 2025 · Sep 30, 2024 −$0.60
Eps Diluted Q3 2025 · Sep 30, 2024 −$1.80
Eps Basic Q3 2025 · Sep 30, 2025 −$0.49
Eps Basic Q3 2025 · Sep 30, 2025 −$1.36
Eps Basic Q3 2025 · Sep 30, 2024 −$0.60
Eps Basic Q3 2025 · Sep 30, 2024 −$1.80
Sga Expense Q3 2025 · Sep 30, 2025 $5.93M
Sga Expense Q3 2025 · Sep 30, 2025 $14.14M
Sga Expense Q3 2025 · Sep 30, 2024 $4.4M
Sga Expense Q3 2025 · Sep 30, 2024 $13.27M
Rd Expense Q3 2025 · Sep 30, 2025 $39.95M
Rd Expense Q3 2025 · Sep 30, 2025 $114.48M
Rd Expense Q3 2025 · Sep 30, 2024 $33.23M
Rd Expense Q3 2025 · Sep 30, 2024 $92.22M
Net Income Q3 2025 · Sep 30, 2025 −$42.22M
Net Income Q3 2025 · Sep 30, 2025 −$116.39M
Net Income Q3 2025 · Sep 30, 2024 −$34.56M
Net Income Q3 2025 · Sep 30, 2024 −$95.91M
Operating Income Q3 2025 · Sep 30, 2025 −$45.88M
Operating Income Q3 2025 · Sep 30, 2025 −$128.61M
Operating Income Q3 2025 · Sep 30, 2024 −$37.62M
Operating Income Q3 2025 · Sep 30, 2024 −$105.49M